Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2003
11/19/2003EP0724634B1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
11/19/2003EP0665890B1 Increased production of secreted proteins by recombinant eukaryotic cells
11/19/2003EP0540573B2 Assay of free and complexed prostate-specific antigen (psa)
11/19/2003CN1128224C Process for production of lipstation and tetraphydrolipstatin
11/18/2003US6649409 Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs
11/18/2003US6649407 Viral fiber protein for use in the treatment of viral diseases
11/18/2003US6649398 Composition for use in the propagation of bacteria
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649375 Adenoviral vectors for enhanced gene expression
11/18/2003US6649374 Recombinant Chlamydia trachomatis PGP3 antigen
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003US6649340 Protein which contains a predetermined amino acid in the hypervariable region of the antigen-binding site; use in studying structure/ function and in developing new enzymes and antibodies
11/18/2003US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/18/2003US6649163 Treatment and diagnosis of cancer
11/18/2003CA2265508C Bone morphogenetic protein-16 (bmp-16) compositions
11/18/2003CA2143845C Self-assembling recombinant papillomavirus capsid proteins
11/18/2003CA2045208C Inhibition of coloration of human serum albumin
11/18/2003CA1341447C Mutant t-pa with kringle replacement
11/18/2003CA1341446C Tissue plasminogen activator analogs having modified growth factor domains
11/17/2003CA2429483A1 Immunointeractive molecules
11/13/2003WO2003093474A1 Psp94 binding protein and psp94 diagnostic assays
11/13/2003WO2003093453A2 Bacillus licheniformis mutant host cell
11/13/2003WO2003093452A2 Variants of nedd4l associated with hypertension and viral budding
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093411A2 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003WO2003093320A2 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses
11/13/2003WO2003093317A1 Antibody to human insulin-like growth factor
11/13/2003WO2003093308A1 Metallo proteinase inhibitory agent
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092619A2 Prevention and treatment of type 2 diabetes
11/13/2003WO2003092610A2 Methods of using cytokine antagonists to treat hiv infection and aids
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003072739A3 Trans-splicing mediated imaging of gene expression
11/13/2003WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof
11/13/2003WO2003068804A3 Novel insect cell line
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003061363A3 Mutations caused by activation-induced cytidine deaminase
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003007886A3 Plant ion channels and methods
11/13/2003WO2003006606A3 Targeted fusion proteins and methods for the characterization of cellular membrane domains
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002079226A3 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
11/13/2003WO2002076406A3 Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
11/13/2003WO2002062825A3 Detection of polymorphisms in the human 5-lipoxygenase gene
11/13/2003WO2002057226A8 68730 and 69112 protein kinase molecules and uses therefor
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents
11/13/2003US20030212259 Recombinant photoproteins and their conjugates
11/13/2003US20030212252 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030211997 Mimetic peptides for an epitope of apolipoprotein B-100, concatemers of the peptides, and modified peptides, and compositions comprising the same
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211965 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211599 Miniature achromosomal and anucleate cell for use as drug delivery system; antitumor/antiproliferative agents
11/13/2003US20030211579 Methods for increasing polypeptide production
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211576 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211573 Preparing glycoprotein in cells using enhanced carbamoyl-phosphate synthase II (CPS II)/aspartate transcarbamoylase (ATCase)/dihydro-orotase (CAD) enzyme; drug delivery and design
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211568 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211114 Vaccine for Pseudomonas aeruginosa
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003US20030211104 Methods of using cytokine antagonists to treat HIV infection and AIDS
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
11/13/2003US20030211098 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
11/13/2003US20030211096 Detection of genes which amplification genome cells; anticancer, antitumor agent
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211086 Minicell-based selective absorption
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2484420A1 Antibodies specific for human cd22 and their therapeutic and diagnostic uses
11/13/2003CA2483912A1 Alcam and alcam modulators
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483047A1 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003CA2480777A1 Methods of using cytokine antagonists to treat hiv infection and aids
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361272A1 Neuritin, a neurogene
11/12/2003EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof
11/12/2003EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene
11/12/2003EP1361267A2 Mesenchymal stem cells and their use
11/12/2003EP1360962A2 Interferon tau composition and methods of use
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1125